Quarterly report pursuant to Section 13 or 15(d)

NOTES PAYABLE

v3.24.1.1.u2
NOTES PAYABLE
3 Months Ended
Mar. 31, 2024
NOTES PAYABLE  
NOTES PAYABLE

NOTE 8. NOTES PAYABLE

 

RELATED PARTIES

 

Related party notes payable consist of the following:

 

 

 

March 31,

2024

 

 

December 31,

2023

 

Non-Convertible Note Payable

 

$ 11,810

 

 

$ 11,810

 

Less Current Portion

 

 

(11,810 )

 

 

(11,810 )

Net Long-Term Portion

 

$ -

 

 

$ -

 

 

 Related Party Non-Convertible Note Payable

 

The Company has one non-convertible note payable to a related party that has a principal balance of $11,810 as of March 31, 2024, and December 31, 2023. The note carries an interest rate at 0%.  The note payable had a due date of December 31, 2012, and is currently in default.

 

NON-RELATED PARTIES 

 

Non-related party notes payable consist of the following:

 

 

 

March 31,

2024

 

 

December 31,

2023

 

Convertible Notes Payable with Warrants - 2023 Debt Offering

 

$ 2,446,828

 

 

$ 3,219,724

 

Convertible Notes Payable

 

 

9,183

 

 

 

9,183

 

Non-Convertible Notes Payable

 

 

17,500

 

 

 

17,500

 

Premium Financing Note Payable

 

 

-

 

 

 

37,648

 

Unamortized Debt Discount

 

 

(572,900 )

 

 

(913,826 )

Net Non-Related Party Notes Payable

 

$ 1,900,611

 

 

$ 2,370,229

 

Current Portion

 

 

(1,900,611 )

 

 

(64,331 )

Net Long-Term Portion

 

$ -

 

 

$ 2,305,898

 

 

Total interest expense for non-related party notes was $40,921 and $41,126 for the three-month periods ended March 31, 2024 and 2023, respectively.

Convertible Notes Payable with Warrants - 2023 Debt Offering

 

On March 7, 2023, the Company entered into a Debt Offering (the “2023 Debt Offering”) pursuant to a Purchase Agreement (the “Agreement”) and Registration Rights Agreement with institutional investors (the “Purchasers”). The 2023 Debt Offering closed on March 9, 2023. The 2023 Debt Offering includes 15% Original Issue Discount Convertible Notes (the “Notes”) and Common Stock Purchase Warrants (the “Warrants”).  Under the terms of the Agreement, the Company received $3,000,001 from the Purchasers and in exchange issued the Notes in principal amounts of $3,529,412 and Warrants to purchase up to 386,998 shares of the Company’s common stock. The Notes are convertible voluntarily by the Purchaser at any time. The principal amounts are convertible into shares of our common stock at a conversion price $2.28. The Notes are due March 10, 2025, and accrue interest quarterly at 5% per annum. The accrued interest is payable by way of inclusion in the convertible amount and is compounded quarterly. The Warrants are exercisable at any time through March 9, 2028, into shares of the Company’s common stock at an exercise price of $2.52 per share. The Company received approximately $2,500,000 of net proceeds from the 2023 Debt Offering after offering-related costs.

 

On May 10, 2023, noteholders elected to convert a total of $341,999 (the “Conversion Amount”) pertaining to the 2023 Debt Offering into 150,000 shares of the Company’s common stock at $2.28 per share. As provided for in the Agreement, the Conversion Amount included original Note principal of $309,688, as well as accrued interest of $32,311.

 

On March 4, 2024, the Company entered into inducement offer letter agreements (the “Inducement Letters”) with each holder (collectively, the “Holders”, and individually, a “Holder”) of the Notes issued on March 9, 2023.

 

Pursuant to the Inducement Letter, the Holders agreed to convert some or all of the Applicable Notes at a reduced conversion price equal to $0.62 per share (such reduced conversion price, the “Notes Conversion Price”). Simultaneously with the execution of the Inducement Letters, the Company received conversion notices from such Holders for the conversion of approximately $804,000 aggregate principal amount of the Applicable Notes, representing approximately 25% of the aggregate principal amount of the Applicable Notes. In connection with such conversion, the Notes Conversion Price was permanently reduced to $0.62.

 

In addition, pursuant to the Inducement Letter, the exercise price in the Common Stock Purchase Warrants issued on March 9, 2023 (the “Applicable Warrants”) currently held by Holders was permanently reduced to $0.62 per share (such reduced exercise price, the “Warrants Exercise Price”).

 

On March 5, 2024, the Holders elected to convert a total of $804,695 (the “Conversion Amount”) pertaining to the 2023 Debt Offering into 1,297,895 shares of the Company’s common stock at $0.62 per share. As provided for in the Agreement, the Conversion Amount included original Note principal of $772,896, as well as accrued interest of $31,799. The Company recognized conversion expense of $585,875 for the induced conversion.

 

Convertible Notes Payable

 

The Company has two convertible notes payable to a non-related entity with principal balances totaling $9,183 as of March 31, 2024, and December 31, 2023.  The notes bear interest at 12% and are convertible into shares of the Company’s common stock at $32.29 per share. The notes were due in 2013 and are currently in default. 

 

Non-Convertible Notes Payable

 

The Company has two non-convertible notes payable to non-related parties with principal balances totaling $17,500 as of March 31, 2024, and December 31, 2023. These notes carry interest rates ranging from 9% - 10% and have due dates ranging from December 2013 to November 2015. The notes are currently in default. 

 

Premium Financing Note Payable

 

On June 15, 2023, the Company entered into a financing agreement for payments of its annual Directors & Officers insurance premiums for coverage from May 2023 through May 2024 totaling $367,352. The financing agreement required an initial down payment of $73,470 with the remaining amount of $293,882 financed for an eight-month period at an annual interest rate of 8.49% with monthly payments of $37,914 beginning in June 2023. The note was paid in full in January 2024.